Nibec나이벡
138610 · KOSDAQ · ₩138610 · 나이벡
₩14,180▼ ₩400 (2.74%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Aug 24, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 5, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 18, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 30, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 30, 2026Open on DART
- Audit report submitted감사보고서제출Mar 20, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 20, 2026Open on DART
- [Attached Correction] Reference Documents for Proxy Solicitation for Exercise of Voting Rights[첨부정정]의결권대리행사권유참고서류Mar 16, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 24, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (나이벡 펩타이드 NP201 호주 임상 1b 임상시험결과)Jan 29, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Sep 5, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Aug 14, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Jun 4, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (NP201 기술이전의 건)May 28, 2025Open on DART
- Adjustment of Conversion Price전환가액의조정May 22, 2025Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득May 22, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 9, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Amended: Audit report submitted[기재정정]감사보고서제출Mar 20, 2025Open on DART
- Audit report submitted감사보고서제출Mar 20, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 10, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Mar 10, 2025Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 10, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 10, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 10, 2025Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Feb 24, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2024Open on DART
- Adjustment of Conversion Price전환가액의조정Nov 22, 2024Open on DART
- Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 13, 2024Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (나이벡 펩타이드 기반 염증성장질환치료제(NIPEP-IBD, 코드명 NP-201) 호주 임상 1b/2a 임상 시험계획 승인)Nov 11, 2024Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (나이벡 펩타이드 기반 NP201 호주 임상 1b/2a 임상 시험계획 신청)Oct 22, 2024Open on DART
- Exercise of Conversion Rights전환청구권행사Oct 17, 2024Open on DART
- Exercise of Conversion Rights전환청구권행사Oct 16, 2024Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (중국시장 독점판매권 회수 및 보상금 지급의 건)Sep 11, 2024Open on DART
- Half-year report (Jun 2024)반기보고서 (2024.06)Aug 13, 2024Open on DART
- Adjustment of Conversion Price전환가액의조정May 22, 2024Open on DART
- Quarterly report (Mar 2024)분기보고서 (2024.03)May 13, 2024Open on DART
- Annual general meeting results정기주주총회결과Mar 29, 2024Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 29, 2024Open on DART
Titles in Korean until English translations are added.
Also known as: Nibec / 나이벡 / 138610 / KRX:138610
Source: KRX statistical information